Topic summary

Secretagogues and glucose tolerance: the mechanistic concern — what changed since

Compounds › Secretagogues & GH axis GHRP class ipamorelin CJC-1295 observational data Wiki Closed

This is a generated summary. It shows the 5 most-liked posts from a topic of 7, in their original order, with the accepted answer included where one exists. It is a reading aid and it will miss nuance — the full topic is the record.

ThibodeauTL3Regular13 Mar 2026#1

Secretagogues and glucose tolerance: the mechanistic concern — what changed since Writing it up because I had to work it out twice and would rather nobody else did.

What changes if the standard account of Secretagogues and glucose tolerance is wrong? I ask because I have been treating it as settled and I noticed this week that I could not say why.

Working through the consequences rather than the evidence, since others here are better placed on the evidence.

13 likes 5mo

l.dziedzicTL230 Mar 2026#2

Confirming the opening post from a second method, which matters more than confirming it from a second person.

Sermorelin and the growth hormone releasing hormone analogues depend on a functioning pituitary response, which is the mechanistic reason they behave differently in different people rather than a dosing problem.

I would put a moderate confidence on that and no more.

1 like 4mo

KLindqvistTL4 Moderator12 Apr 2026#3

Community wiki post. Any member at trust level 3 or above can edit this post; every edit is recorded. Last edited by buffer_sheet on 11 Jun 2026.

31 May 2026 — NLoughran: Replaced an unsourced figure with the published one and cited it.
11 Jun 2026 — buffer_sheet: Removed a claim that the cited source did not support.

Editors: NLoughran, buffer_sheet, d.szymanski, r.venkatesan

Evidence quality in the secretagogue literature is honestly weaker than in the incretin literature. Large randomised controlled trials are rare. Most evidence is mechanistic or from small studies. This is why this subcategory has higher sourcing standards than most.

0 likes 4mo

a.ibarraTL223 Apr 2026#4

Reading a rodent study on a secretagogue without over-extrapolating: rodent studies can show a mechanism is plausible. They cannot show magnitude of effect in humans or safety profile in humans. That gap is larger for secretagogues than for incretin agonists because the human evidence is thinner.

Where I would look next, rather than where I would stop.

17 likes 3mo

e.ferrariTL23 May 2026#5

Coming back to the opening post, because the follow-up matters more than the original answer.

Secretagogues and glucose tolerance: there is a mechanistic concern that sustained growth hormone elevation might impair glucose tolerance. The clinical relevance of this concern in practice is not well established.

11 likes 3mo

Read the full topic (7 posts)

This topic was referenced in

Why this subcategory is stricter about sourcing than mostCompounds › Secretagogues & GH axis · 52 replies

This topic was closed 45 days after the last reply. Closing is automatic for quiet topics so that a settled answer does not collect new questions underneath it. If you have a follow-up, open a new topic and link back to this one — that keeps both readable and gives your question its own title.

Moved from Oral incretins by dr_okonkwo. Category placement is not obvious from outside and getting it wrong is expected. This topic will get better answers here. The move is recorded in the public log citing R7.

Suggested topics

Topic	Participants	Replies	Views	Activity
Revisiting: What a well-designed human trial of a secretagogue would look like Compounds › Secretagogues & GH axis CJC-1295 observational data needs a source GHRP class On the subject in the title: Revisiting: What a well-designed human trial of a secretagogue would look like Working notes rather than a conclusion. Something about well-designed human trial does not reconcile…	+69	74	25k	18mo
Reading a rodent study on a secretagogue without over-extrapolating Compounds › Secretagogues & GH axis observational data GHRP class CJC-1295 needs a source Closed Posting this under the heading it deserves: Reading a rodent study on a secretagogue without over-extrapolating Everything below is what sits behind that. Reading a rodent study, and specifically the version…	+50	54	32k	10mo
Why pulsatile secretion matters for interpreting secretagogue claims — a second dataset Compounds › Secretagogues & GH axis GHRP class ipamorelin tesamorelin Under review The question in the title: Why pulsatile secretion matters for interpreting secretagogue claims — a second dataset I will give what I have already checked below so nobody repeats it. Posting a small dataset…	+60	64	25k	15mo
Ipamorelin selectivity claims and where they came from Compounds › Secretagogues & GH axis GHRP class tesamorelin ipamorelin Closed Ipamorelin selectivity claims and where they came from — setting out what I have, and where I think it stops being reliable. Ipamorelin selectivity claims, from the point of view of someone who has read the…	+51	56	8.8k	12mo
IGF-1 as a surrogate endpoint and its limitations Compounds › Secretagogues & GH axis GHRP class needs a source observational data tesamorelin IGF-1 as a surrogate endpoint and its limitations Writing it up because I had to work it out twice and would rather nobody else did. IGF-1, and specifically the version of it that the documentation does not…	+5	9	35k	4mo

Related topics — sharing the tags GHRP class, ipamorelin, CJC-1295

Topic	Participants	Replies	Views	Activity
Revisiting: Why the absence of controlled human data on BPC-157 matters more than people admit Compounds › Repair & healing peptides observational data TB-500 BPC-157 preprint Solved Revisiting: Why the absence of controlled human data on BPC-157 matters more than people admit Writing it up because I had to work it out twice and would rather nobody else did. A follow-up question about…	+50	55	7.8k	2d
BPC-157: what the rodent literature actually shows, and what it does not Compounds › Repair & healing peptides observational data preprint BPC-157 needs a source BPC-157: what the rodent literature actually shows, and what it does not — setting out what I have, and where I think it stops being reliable. I would like to know what people here actually do about BPC-157,…	+44	48	3k	10mo
Analytical identity of BPC-157: a 15-mer with a simple mass Compounds › Repair & healing peptides BPC-157 observational data needs a source preprint Analytical identity of BPC-157: a 15-mer with a simple mass Writing it up because I had to work it out twice and would rather nobody else did. Something about analytical identity of BPC-157 does not reconcile…	+3	7	5.2k	10mo
Cleaning a self-reported dataset and what you throw away Data & Tools › Datasets confounding site feedback data table observational data Cleaning a self-reported dataset and what you throw away — setting out what I have, and where I think it stops being reliable. Collecting what is known about cleaning a self-reported dataset in one place,…		2	28k	1d
[2026 update] Evidence quality in the secretagogue literature: an honest assessment Compounds › Secretagogues & GH axis CJC-1295 GHRP class tesamorelin Closed Posting this under the heading it deserves: Evidence quality in the secretagogue literature: an honest assessment Everything below is what sits behind that. I have spent a fortnight trying to pin Evidence…	+14	18	3.1k	6mo